Status:
UNKNOWN
Evaluation of the Effectiveness of the TOVERTAFEL System on Behavioral Disorders
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Behavioral Disorder
Eligibility:
All Genders
60-106 years
Phase:
NA
Brief Summary
The prevalence of behavioral disorders is high in patients living in an institutional environment or hospitalized in a long-term care unit. The consequences of these symptoms are not negligible with a...
Eligibility Criteria
Inclusion
- Man or woman aged 60 to 106.
- Patient living in one of the USLD or UHR participating in the project.
- Score greater than or equal to 9 for at least one of the following items in the NPI-ES: apathy, agitation, anxiety, depression, aberrant motor behavior.
- Presence of TNC according to the standardization and calibration of the MMSE.
- The patients recruited must have given themselves, or through a trusted person provided for in article L. 1111-6 of the Public Health Code, failing this, by the family, or, failing that, by a person having close and stable ties with the person concerned; for adults under guardianship: the guardian or legal representative, for adults under guardianship: the curator, their informed consent to this study which must be approved by the Personal Protection Committee (PPC) prior to its completion.
Exclusion
- Unstable pathology whose nature can interfere with the evaluation variables
- Deafness or blindness which could compromise the patient's assessment or his participation in the animation sessions.
Key Trial Info
Start Date :
September 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2021
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04421833
Start Date
September 10 2020
End Date
August 1 2021
Last Update
July 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital des Charpennes
Villeurbanne, France, 69100